ARVN Competitors & Alternatives
Compare Arvinas Inc with similar stocks in the same industry
Biotechnology
ARVN
Main Stock$6.78
-0.59%
Tradestie Score
54
Market Cap
$670.30M
Revenue Growth
-98.8%
Analyst Upside
+106.5%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
-9.16%
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.73
-8.58%
|
$468.01M | - | 44 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$9.11
-2.77%
|
$463.20M | - | 44 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$6.56
-4.17%
|
$457.09M | - | 37 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.46
-1.06%
|
$454.29M | - | 55 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
+0.07%
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$11.94
-4.52%
|
$448.32M | - | 33 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
+0.64%
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$5.06
-9.65%
|
$422.50M | - | 43 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$11.65
-4.74%
|
$407.71M | - | 52 | Compare |
More ARVN Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry